Temperature:: The single most important factor for degradation of glucose fluids during storage

被引:9
作者
Kjellstrand, P [1 ]
Erixon, M [1 ]
Wieslander, A [1 ]
Lindén, T [1 ]
Martinson, E [1 ]
机构
[1] Gambro AB, S-22010 Lund, Sweden
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2004年 / 24卷 / 04期
关键词
glucose degradation; storage; biocompatibility; fluid; glucose degradation products; shelf life; heat sterilization; 3,4-dideoxyglucosone-3-ene; 3,4-DGE; 5-hydroxymethyl-2-furaldehyde; 5-HMF;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective: Bioincompatible glucose degradation products (GDPs) develop during heat sterilization of peritoneal dialysis (PD) fluids. However, degradation may also take place during storage. Consequently, storage may add to the bioincompatibility caused by heat sterilization. The aim of the present study was to investigate how different factors such as the sterilization procedure, pH, glucose concentration, and temperature influence GDP production during storage. Design: Degradation in glucose solutions was followed by pH and UV absorbance at 228 nm and 284 nm over 2 years of storage. Different sterilization times, storage temperatures, pH, and glucose concentrations were included in the study. Peritoneal dialysis fluids were also used in the experiment. Bioincompatibility was estimated through inhibition of cell growth in L-929 fibroblasts, and GDPs through UV absorption and liquid chromatography. Results:The most important factor determining the rate of GDP production during storage was temperature. The GDPs created by heat sterilization promoted further degradation of glucose during subsequent storage. A pH of around 3.2 protected glucose from degradation during both heat sterilization and storage. At a storage temperature of 20degreesC and a pH of 3.2, degradation was almost negligible. Heat sterilization produced considerable amounts of GDPs absorbing at 228 nm. During initial storage, these 228 nm-absorbing GDPs almost disappeared. After reaching a nadir, absorbance at 228 nm again started to increase. Contrary to this, absorbance at 284 nm [caused mainly by 5-hydroxymethyl-2-furaldehyde (5-HMF)] increased during the whole storage period. After 2 years at 40degreesC, the concentrations of GDPs produced during storage were of the same magnitude as those caused by heat sterilization. Inhibition of cell growth of L-929 fibroblasts correlated well with the part of the absorbance at 228 nm not caused by 5-HMF in glucose solutions that were heat sterilized under a wide range of conditions. This part of 228 nm absorbance (denoted 228(corr)) was caused almost entirely by 3,4-dideoxyglucosone-3-ene (3,4-DGE). Conclusions: Temperature is the single most important factor for glucose degradation during storage. The concentrations of bioincompatible GDPs produced may, under improper conditions, be as high as those produced during sterilization. High concentrations of glucose and low pH protect glucose from being degraded during both sterilization and storage. A good estimate of 3,4-DGE concentration in the fluids can be, obtained correcting the UV absorbance at 228 nm for the influence from 5-HMF (and, when appropriate, for lactate). The 228(corr) may thus be used as a simple quality control for the fluids.
引用
收藏
页码:385 / 391
页数:7
相关论文
共 16 条
[1]
HENDERSON IS, 1986, PERITONEAL DIALYSIS, P85
[2]
KJELLSTRAND P, 1995, PERITON DIALYSIS INT, V15, P26
[3]
Kjellstrand P, 2001, PERITON DIALYSIS INT, V21, P338
[4]
3,4-Dideoxyglucosone-3-ene (3,4-DGE): A cytotoxic glucose degradation product in fluids for peritoneal dialysis [J].
Linden, T ;
Cohen, A ;
Deppisch, R ;
Kjellstrand, P ;
Wieslander, A .
KIDNEY INTERNATIONAL, 2002, 62 (02) :697-703
[5]
Linden T, 2001, PERITON DIALYSIS INT, V21, P607
[6]
Linden T, 1998, PERITON DIALYSIS INT, V18, P290
[7]
Martinson E, 1992, ASAIO J, V38, pM370, DOI 10.1097/00002480-199207000-00057
[8]
Impact of terminal heat sterilization on the quality of peritoneal dialysis solutions [J].
Martis, L ;
Henderson, LW .
BLOOD PURIFICATION, 1997, 15 (01) :54-60
[9]
NILSSONTHORELL CB, 1993, PERITON DIALYSIS INT, V13, P208
[10]
Rippe B, 1997, PERITON DIALYSIS INT, V17, P27